Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Beta-blockers inferior to other hypertension treatments | GE Healthcare's new AI offering | AFib ablation protocols

News You Need to Know Today
Beta-blockers inferior to other hypertension treatments | GE Healthcare's new AI offering | AFib ablation protocols
Wednesday, March 31, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

The blood clot plot continues: Countries suspend use of AstraZeneca COVID-19 vaccine in younger adults

The ongoing saga continues. Both Germany and Canada have now limited the use of the AstraZeneca vaccine among younger adults. 

READ MORE >
vaccine syringe covid-19 coronavirus
Share on Twitter Share on Facebook Share on Linkedin

The blood clot plot continues: Countries suspend use of AstraZeneca COVID-19 vaccine in younger adults

Share on Twitter Share on Facebook Share on Linkedin
vaccine syringe covid-19 coronavirus
The ongoing saga continues. Both Germany and Canada have now limited the use of the AstraZeneca vaccine among younger adults. 
READ MORE >

Beta-blockers are inferior to other antihypertensive treatment options, new research confirms

The authors tracked outcomes from more than 386,000 patients treated from 2001 to 2018, sharing their findings in Hypertension.

READ MORE >
Blood Pressure
Share on Twitter Share on Facebook Share on Linkedin

Beta-blockers are inferior to other antihypertensive treatment options, new research confirms

Share on Twitter Share on Facebook Share on Linkedin
Blood Pressure
The authors tracked outcomes from more than 386,000 patients treated from 2001 to 2018, sharing their findings in Hypertension.
READ MORE >

GE Healthcare debuts new AI offering for cardiac imaging

The new AI tool can be used alongside GE Healthcare’s full line of Venue ultrasound systems, including the new Venue Fit. 

READ MORE >
As artificial intelligence (AI) adoption expands in radiology, there is growing concern that AI algorithms needs to undergo quality assurance (QA) reviews. How to validate radiology AI? How can you validate medical imaging AI?
Share on Twitter Share on Facebook Share on Linkedin

GE Healthcare debuts new AI offering for cardiac imaging

Share on Twitter Share on Facebook Share on Linkedin
As artificial intelligence (AI) adoption expands in radiology, there is growing concern that AI algorithms needs to undergo quality assurance (QA) reviews. How to validate radiology AI? How can you validate medical imaging AI?
The new AI tool can be used alongside GE Healthcare’s full line of Venue ultrasound systems, including the new Venue Fit. 
READ MORE >

New and improved: Hospital updates AFib ablation protocols, improves efficiency

“Value can be defined as delivered care divided by cost,” the specialists wrote. “Ideally, each patient receives the same good quality of care in an equitable, timely way.”

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

New and improved: Hospital updates AFib ablation protocols, improves efficiency

Share on Twitter Share on Facebook Share on Linkedin
“Value can be defined as delivered care divided by cost,” the specialists wrote. “Ideally, each patient receives the same good quality of care in an equitable, timely way.”
READ MORE >

Featured Articles

TMVR safe and effective for kidney transplant recipients

One important detail, however, was that acute kidney injury was more common for kidney transplant recipients. The researchers listed numerous potential explanations for this trend.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

TMVR safe and effective for kidney transplant recipients

Share on Twitter Share on Facebook Share on Linkedin
One important detail, however, was that acute kidney injury was more common for kidney transplant recipients. The researchers listed numerous potential explanations for this trend.
READ MORE >

Working long hours increases the likelihood of a second heart attack

The analysis, published in the Journal of the American College of Cardiology, tracked nearly 1,000 patients treated for their first myocardial infarction from November 1995 to October 1997.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Working long hours increases the likelihood of a second heart attack

Share on Twitter Share on Facebook Share on Linkedin
The analysis, published in the Journal of the American College of Cardiology, tracked nearly 1,000 patients treated for their first myocardial infarction from November 1995 to October 1997.
READ MORE >

‘A new treatment option’: FDA approves Harmony TPV, says it could delay the need for certain surgeries

The solution’s approval was based on 30-day and six-month data from a clinical study focused on mortality and hemodynamic function.

READ MORE >
Approved
Share on Twitter Share on Facebook Share on Linkedin

‘A new treatment option’: FDA approves Harmony TPV, says it could delay the need for certain surgeries

Share on Twitter Share on Facebook Share on Linkedin
Approved
The solution’s approval was based on 30-day and six-month data from a clinical study focused on mortality and hemodynamic function.
READ MORE >

In Other News

Prestigious provider org joins with storied tech giant to ‘accelerate discovery’

Two healthcare heavyweights are combining forces to form a technology center they hope will, over the next 10 years, “fundamentally advance the pace” of discovery in medical science and healthcare innovation.

READ MORE >
IBM
Share on Twitter Share on Facebook Share on Linkedin

Prestigious provider org joins with storied tech giant to ‘accelerate discovery’

Share on Twitter Share on Facebook Share on Linkedin
IBM
Two healthcare heavyweights are combining forces to form a technology center they hope will, over the next 10 years, “fundamentally advance the pace” of discovery in medical science and healthcare innovation.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Week in Review: Abbott exec plans exit | IVL competition heats up | ASNC favors PET | Medtech companies speak out | AI for POCUS
Faster treatments, better outcomes | Robotic heart surgery gains momentum | Cath lab strategies | TAVR's next challenge
Tap water linked to potential risks | New cardiac care certification announced | FDA clears AI software | Post-stroke injections
ASNC chooses PET | Comparing OBLs & ASCs | TMVR device gains approval | The risks of HF | Paradoxical low-flow, low gradient AS
Key takeaways from new stroke guideline | The fight over certification | AI for POCUS | A PET trend to watch | Abbott VP to exit
Cath labs work to stay ahead | Feedback rolls in as CMS considers TAVR changes | FDA approves new stent for deep venous disease
Minnesota companies speak out | Exploring IVL trends | Robotic cardiac surgery building momentum | Cannabis & patient outcomes

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …24
    • Page 25
    • Page 26
    • Page 27
    • Current page 28
    • Page 29
    • Page 30
    • Page 31
    • Page 32 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme